These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 15472471
21. Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents. Hashiguchi Y, Hamada A, Shinohara T, Tsuchiya K, Jono H, Saito H. Biochem Biophys Res Commun; 2013 Sep 20; 439(2):221-7. PubMed ID: 23981805 [Abstract] [Full Text] [Related]
22. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein. Takara K, Tanigawara Y, Komada F, Nishiguchi K, Sakaeda T, Okumura K. Jpn J Cancer Res; 2000 Feb 20; 91(2):248-54. PubMed ID: 10761713 [Abstract] [Full Text] [Related]
30. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Wandel C, Kim R, Wood M, Wood A. Anesthesiology; 2002 Apr 20; 96(4):913-20. PubMed ID: 11964599 [Abstract] [Full Text] [Related]
31. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus. Wang R, Sun X, Deng YS, Qiu XW. Xenobiotica; 2019 Nov 20; 49(11):1373-1378. PubMed ID: 30587068 [Abstract] [Full Text] [Related]
32. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Lecureur V, Sun D, Hargrove P, Schuetz EG, Kim RB, Lan LB, Schuetz JD. Mol Pharmacol; 2000 Jan 20; 57(1):24-35. PubMed ID: 10617675 [Abstract] [Full Text] [Related]
36. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1. Takeuchi T, Yoshitomi S, Higuchi T, Ikemoto K, Niwa S, Ebihara T, Katoh M, Yokoi T, Asahi S. Pharm Res; 2006 Jul 20; 23(7):1460-72. PubMed ID: 16779700 [Abstract] [Full Text] [Related]
37. Is aspirin a substrate of MDR1/P-glycoprotein? Singh R, Naik T, Nigam A, Chatterjee S, Rajanna P, Shen H, Iyer R. Xenobiotica; 2020 Oct 20; 50(10):1258-1264. PubMed ID: 32302241 [Abstract] [Full Text] [Related]
38. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1. Ito T, Yano I, Tanaka K, Inui KI. J Pharmacol Exp Ther; 1997 Aug 20; 282(2):955-60. PubMed ID: 9262363 [Abstract] [Full Text] [Related]
39. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. Salama NN, Yang Z, Bui T, Ho RJ. J Pharm Sci; 2006 Oct 20; 95(10):2293-308. PubMed ID: 16883550 [Abstract] [Full Text] [Related]
40. Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse. Booth-Genthe CL, Louie SW, Carlini EJ, Li B, Leake BF, Eisenhandler R, Hochman JH, Mei Q, Kim RB, Rushmore TH, Yamazaki M. J Pharmacol Toxicol Methods; 2006 Oct 20; 54(1):78-89. PubMed ID: 16545584 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]